About PFC Pharma Focus India
PFC Pharma Focus India is a Healthcare company. Clinical trial management services in pharmaceuticals and biotechnology. Its Indian entity Pfc Pharma Focus India Private Limited reported revenue of ₹61 Lakh. PFC Pharma Focus India offers products and services including Site Selection and Feasibility Studies and Regulatory and Study Start-Up. Its focus areas include Biotechnology, Drug Development, Services and Pharmaceuticals.
Company details
PFC Pharma Focus India is noted for offering comprehensive trial management services in Phase I-IV clinical trials across various therapeutic areas, serving global pharmaceutical, biotechnology, medical device, and nutraceutical industries. Indias healthcare sector has been expanded as the seventh-largest country by area, with the hospital industry projected to grow to US 132.84 billion by FY22 and the overall sector to US 372 billion by 2022. Advantages like cost reductions, policy support attracting US 17.74 billion in FDI, and faster clinical trial approvals are utilized to accelerate the development of safe medical therapeutics, contributing to global drug innovation.
- SectorsHealthcare
- Phone•••• ••••
- Website pfcpharma.com
- Legal Name Pfc Pharma Focus India Pvt Ltd
- Date of Incorporation 23 Jun, 2008
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹61 Lakh
FY 2024 · -42% YoY
- Indian entity net loss-₹45.8 Lakh
FY 2024 · -75% margin
- Indian entity EBITDA-₹41.5 Lakh
FY 2024 · -68% margin
Associated legal entities of PFC Pharma Focus India
PFC Pharma Focus India operates through Pfc Pharma Focus India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pfc Pharma Focus India Private Limited CIN U24232DL2008PTC179947 | Active | 23 Jun 2008 | New Delhi, Delhi | ₹0.6 Cr | 3 | View details |
Products & Services of PFC Pharma Focus India
PFC Pharma Focus India offers a comprehensive portfolio of products and services, including Site Selection and Feasibility Studies and Regulatory and Study Start-Up.
Services for selecting and assessing sites for clinical trials are delivered to support effective trial planning.
Support for regulatory affairs and the initiation of studies is provided to facilitate compliance and timely commencement.
Board of directors of Pfc Pharma Focus India Private Limited (PFC Pharma Focus India)
Pfc Pharma Focus India Private Limited is the primary company behind PFC Pharma Focus India. The board of Pfc Pharma Focus India Private Limited currently have 3 directors; the longest-serving is Kavitha Jeya Pushparani Joseph, appointed in 2021. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kavitha Jeya Pushparani Joseph DIN 09064833 | Director | 12 Feb 2021 | 5 yrs 8 mo | Pfc Pharma Focus India Private Limited |
| Joseph Innocent Babola Stanislaus Amalraj DIN 08183194 | Director | 25 Jul 2022 | 4 yrs 3 mo | Pfc Pharma Focus India Private Limited |
| Saurendra Das DIN 01220407 | Additional Director | 15 Oct 2024 | 2 yrs | Pfc Pharma Focus India Private Limited |
Financials of PFC Pharma Focus India
Figures of Pfc Pharma Focus India Private Limited, the primary company behind PFC Pharma Focus India, for FY 2024. Revenue was ₹61 Lakh (-42% year on year). Net loss was -₹45.8 Lakh (-75% margin). EBITDA was -₹41.5 Lakh (-68% margin). Revenue has grown at a compounded annual rate of -38% over three years and -14% over five years.
- ₹61 LakhRevenue · FY 2024 · -42% YoY
- -₹45.8 LakhNet loss · -75% margin
- -₹41.5 LakhEBITDA · -68% margin
- ₹24.3 LakhPaid-up capital
- -38%Revenue CAGR, 3 years
- -14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pfc Pharma Focus India Private Limited are on its company page.
Detailed financial statements for PFC Pharma Focus India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PFC Pharma Focus India
The primary company behind PFC Pharma Focus India, Pfc Pharma Focus India Private Limited, reported revenue of ₹61 Lakh for FY 2024, down 42% year on year.
PFC Pharma Focus India is noted for offering comprehensive trial management services in Phase I-IV clinical trials across various therapeutic areas, serving global pharmaceutical, biotechnology, medical device, and nutraceutical industries. Indias healthcare sector has been expanded as the seventh-largest country by area, with the hospital industry projected to grow to US 132.84 billion by FY22 and the overall sector to US 372 billion by 2022. Advantages like cost reductions, policy support attracting US 17.74 billion in FDI, and faster clinical trial approvals are utilized to accelerate the development of safe medical therapeutics, contributing to global drug innovation.
PFC Pharma Focus India offers Site Selection and Feasibility Studies and Regulatory and Study Start-Up.
PFC Pharma Focus India operates through Pfc Pharma Focus India Private Limited.
The legal entities of PFC Pharma Focus India currently have 3 directors, including Kavitha Jeya Pushparani Joseph, Joseph Innocent Babola Stanislaus Amalraj, Saurendra Das.